GE HealthCare Technologies Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $20.6B | $19.7B | $19.6B | $18.3B | $17.6B |
| Gross profit | $8.2B | $8.2B | $7.9B | $7.2B | $7.2B |
| Operating income | $2.8B | $2.6B | $2.4B | $2.5B | $2.8B |
| Operating expenses | $5.5B | $5.6B | $5.5B | $4.7B | $4.4B |
| Cash from operations | $2.0B | $2.0B | $2.1B | $2.1B | $1.6B |
| Capital expenditure | $482.0M | $401.0M | $387.0M | $310.0M | $248.0M |
| Free cash flow | $1.5B | $1.6B | $1.7B | $1.8B | $1.4B |
| Share repurchases | $200.0M | $0 | $0 | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $36.9B | $33.1B | $32.5B | $27.5B | — |
| Total liabilities | $26.3B | $24.4B | $25.1B | $17.9B | — |
| Total debt | $10.0B | $9.0B | $9.5B | $8.3B | — |
Shares outstanding 454.9M · Free float 99.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.